CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

4
1
NAS:CRSP (Switzerland)   Ordinary Shares
$ 71.47 -1.48 (-2.03%) 11:08 PM EST
At Loss
P/B:
3.04
Volume:
1.10M
Avg Vol (2M):
2.06M
Also Trade In:
Volume:
1.10M
At Loss
Avg Vol (2M):
2.06M

Business Description

CRISPR Therapeutics AG logo
CRISPR Therapeutics AG

ISIN : CH0334081137

Share Class Description:

CRSP: Ordinary Shares
Description
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, exa-cel, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt 7.1
Equity-to-Asset 0.84
Debt-to-Equity 0.13
Debt-to-EBITDA -1.18
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.42
Distress
Grey
Safe
Beneish M-Score 547.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 17.07
9-Day RSI 29.99
14-Day RSI 39.88
6-1 Month Momentum % 72.59
12-1 Month Momentum % 79.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.54
Quick Ratio 17.54
Cash Ratio 15.57
Days Sales Outstanding 133.18
Days Payable 92.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.7
Shareholder Yield % 0.01

Financials (Next Earnings Date:2024-05-08 Est.)

CRSP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CRSP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CRISPR Therapeutics AG Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 370
EPS (TTM) ($) -1.93
Beta 1.58
Volatility % 89.78
14-Day RSI 39.88
14-Day ATR ($) 3.895409
20-Day SMA ($) 80.36625
12-1 Month Momentum % 79.76
52-Week Range ($) 37.55 - 91.1
Shares Outstanding (Mil) 80.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CRISPR Therapeutics AG Filings

Filing Date Document Date Form
No Filing Data

CRISPR Therapeutics AG Stock Events

Financials Calendars
Event Date Price($)
No Event Data

CRISPR Therapeutics AG Frequently Asked Questions

What is CRISPR Therapeutics AG(CRSP)'s stock price today?
The current price of CRSP is $71.47. The 52 week high of CRSP is $91.10 and 52 week low is $37.55.
When is next earnings date of CRISPR Therapeutics AG(CRSP)?
The next earnings date of CRISPR Therapeutics AG(CRSP) is 2024-05-08 Est..
Does CRISPR Therapeutics AG(CRSP) pay dividends? If so, how much?
CRISPR Therapeutics AG(CRSP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1